4//SEC Filing
Harry Yuval 4
Accession 0001562180-24-002999
CIK 0001828105other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:10 PM ET
Size
22.1 KB
Accession
0001562180-24-002999
Insider Transaction Report
Form 4
Harry Yuval
Chief Revenue Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-22$8.50/sh+3,333$28,331→ 154,102 total - Sale
Common Stock
2024-03-22$17.25/sh−1,752$30,223→ 158,348 total - Sale
Common Stock
2024-03-22$17.20/sh−3,333$57,317→ 149,017 total - Sale
Common Stock
2024-03-22$17.18/sh−3,855$66,226→ 145,162 total - Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−3,855→ 0 totalExercise: $8.50Exp: 2029-01-22→ Common Stock (3,855 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−3,333→ 0 totalExercise: $8.50Exp: 2029-05-14→ Common Stock (3,333 underlying) - Exercise/Conversion
Stock Options (Right to buy)
2024-03-22−5,998→ 0 totalExercise: $4.00Exp: 2028-01-23→ Common Stock (5,998 underlying) - Exercise/Conversion
Common Stock
2024-03-22$8.50/sh+3,855$32,768→ 150,769 total - Exercise/Conversion
Common Stock
2024-03-22$4.00/sh+5,998$23,992→ 160,100 total - Sale
Common Stock
2024-03-22$17.19/sh−5,998$103,117→ 152,350 total
Footnotes (8)
- [F1]This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price.
- [F2]This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price.
- [F5]Includes 94,719 RSUs.
- [F6]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023.
- [F7]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023.
- [F8]The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022.
Documents
Issuer
Hippo Holdings Inc.
CIK 0001828105
Entity typeother
Related Parties
1- filerCIK 0001969714
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:10 PM ET
- Size
- 22.1 KB